Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al
- PMID: 32737109
- DOI: 10.1136/annrheumdis-2020-218173
Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al
Keywords: autoimmune diseases; hydroxychloroquine; lupus erythematosus; systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.Ann Rheum Dis. 2021 May;80(5):e69. doi: 10.1136/annrheumdis-2020-218154. Epub 2020 Jul 31. Ann Rheum Dis. 2021. PMID: 32737111 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical